CVRX - CVRx, Inc.
About CVRx, Inc. (https://www.barostim.com)
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Kevin Hykes | President, Chief Executive Officer & Director | 1966 | $2,635,721 USD |
| Philip Adamson | Chief Medical Officer | 1961 | $1,101,943 USD |
| Paul Verrastro | Interim Head of Sales | 1963 | $598,972 USD |
| Jared Oasheim | Consultant | 1983 | $517,269 USD |
| Bonnie Handke | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | – | – |
| Brent Binkowski | Chief Operating Officer | 1969 | – |
| Gregory Morrison | Chief Human Resources Officer | 1964 | – |
| Matt Klein | Vice President, Legal & Compliance Officer | – | – |
| Patrick Lyon | Vice President of Marketing | – | – |